Anzeige
Mehr »
Dienstag, 21.04.2026 - Börsentäglich über 12.000 News
BREAKING: Pacifica liefert hochgradige Treffer - Phase II trifft genau ins Ziel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
20:18Pratt & Whitney invests $100M to expand US engine maintenance facilities
20:18Pratt & Whitney invests over $100M in U.S. engine maintenance sites
20:18Adtran partners with GLDS for automated Wi-Fi management system
20:18PlusAI terminates SPAC merger with Churchill Capital IX
20:18Microsoft faces UK lawsuit over cloud computing licence pricing
20:06Valero downgraded despite strong earnings outlook as valuation concerns mount
19:54Independent Bank declares $0.28 quarterly dividend
19:54Omnicom partners with Adobe on AI marketing solution
19:54Raymond James raises MSCI stock price target on sales momentum
19:30Muted Growth, Rising AI Disruption: IT Services Sector Faces Uncertain 2026
19:30Jefferies cuts Tractor Supply stock price target on comp outlook
19:30Stifel reiterates Summit Therapeutics stock rating on trial data
19:18Corcept to present ovarian cancer trial data at ASCO meeting
19:18Eaton declares $1.10 quarterly dividend, payable May 29
19:06FDJ United names Dan Lévy as new chief financial officer
19:06Jefferies raises 3M stock price target on strong earnings beat
18:54Tata Steel acquires 26% stake in TP Adarsh for ?59 million
18:42Sweden's Einride to deploy 75 electric trucks for Amazon's US freight network
18:30YouGov director purchases shares worth £20,000
18:18Stifel reiterates Halliburton stock Buy rating on Q1 beat
17:54ZIGUP insider sells shares worth £150,000 on London exchange
17:54Jefferies cuts Clorox stock price target on cost pressures
17:54Arcus Biosciences stock rating held at Neutral by BofA on rival trial data
17:54Jefferies reiterates Churchill Downs stock rating on Preakness deal
17:42Revolution Medicines to present phase 3 pancreatic cancer data at ASCO